Nothing Special   »   [go: up one dir, main page]

JP5381718B2 - Halopolycyclic aromatic compound and method for producing the same - Google Patents

Halopolycyclic aromatic compound and method for producing the same Download PDF

Info

Publication number
JP5381718B2
JP5381718B2 JP2009551442A JP2009551442A JP5381718B2 JP 5381718 B2 JP5381718 B2 JP 5381718B2 JP 2009551442 A JP2009551442 A JP 2009551442A JP 2009551442 A JP2009551442 A JP 2009551442A JP 5381718 B2 JP5381718 B2 JP 5381718B2
Authority
JP
Japan
Prior art keywords
general formula
ring
aromatic compound
halopolycyclic
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009551442A
Other languages
Japanese (ja)
Other versions
JPWO2009096202A1 (en
Inventor
修一 杉田
栄作 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Inc
Original Assignee
Konica Minolta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Inc filed Critical Konica Minolta Inc
Priority to JP2009551442A priority Critical patent/JP5381718B2/en
Publication of JPWO2009096202A1 publication Critical patent/JPWO2009096202A1/en
Application granted granted Critical
Publication of JP5381718B2 publication Critical patent/JP5381718B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Electroluminescent Light Sources (AREA)

Description

本発明は、有機合成化合物の中間体、特に有機エレクトロルミネッセンス材料の中間体として有用なハロ多環芳香族化合物、及びその製造方法に関する。   The present invention relates to an intermediate of an organic synthetic compound, in particular, a halopolycyclic aromatic compound useful as an intermediate of an organic electroluminescent material, and a method for producing the same.

カルバゾイル基が二つ置換した対称形を有するジカルバゾリル多環芳香族化合物を合成する方法において、有用な中間体が知られている。例えば、ジベンゾフランの場合、2,7−ジブロモジベンゾフランまたは2,7−ジヨードジベンゾフランを合成中間体として用いることが可能である。(例えば、非特許文献1参照。)
しかしながら、非対称形を有するジカルバゾリル多環芳香族化合物を合成する際に、これらの中間体を用いると反応制御が困難であり、一つのカルバゾイル基のみが置換した2−カルバゾリル−7−ハロジベンゾフランと同時にカルバゾイル基が2つ置換したものが副生してしまい、収率が大きく低下するという問題があった。
Kryska Anna et al.,J.Chem.Res.Miniprint.10;2501〜2517(1999)
A useful intermediate is known in a method for synthesizing a dicarbazolyl polycyclic aromatic compound having a symmetrical form in which two carbazoyl groups are substituted. For example, in the case of dibenzofuran, 2,7-dibromodibenzofuran or 2,7-diiododibenzofuran can be used as a synthetic intermediate. (For example, refer nonpatent literature 1.)
However, when synthesizing a dicarbazolyl polycyclic aromatic compound having an asymmetric form, it is difficult to control the reaction if these intermediates are used, and simultaneously with 2-carbazolyl-7-halodibenzofuran in which only one carbazoyl group is substituted. There was a problem that the yield of the carbazoyl group substituted was by-produced and the yield was greatly reduced.
Kryska Anna et al. , J .; Chem. Res. Miniprint. 10; 2501-2517 (1999)

従って、本発明は上記問題点を解決すべくなされたものであり、非対称形を有する多環芳香族化合物を高収率で合成する際に有用な中間体であるハロ多環芳香族化合物、及びその製造方法を提供することにある。   Accordingly, the present invention has been made to solve the above-described problems, and is a halopolycyclic aromatic compound that is an intermediate useful in synthesizing a polycyclic aromatic compound having an asymmetric form in a high yield, and It is in providing the manufacturing method.

上記課題は、以下の構成により解決することができた。   The above problem could be solved by the following configuration.

1.下記一般式[1]で表される化合物を用い下記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。   1. The manufacturing method of the halo polycyclic aromatic compound characterized by manufacturing the halo polycyclic aromatic compound represented by the following general formula [2] using the compound represented by the following general formula [1].

(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。Xはハロゲン原子を表す。)
2.前記一般式[1]で表される化合物を用い、リチオ化剤を反応させた後、ボロン酸誘導体と反応させて前記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とする前記1に記載のハロ多環芳香族化合物の製造方法。
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other bound good .X 1 to form a ring with the .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)
2. The compound represented by the general formula [1] is reacted with a lithiating agent and then reacted with a boronic acid derivative to produce a halopolycyclic aromatic compound represented by the general formula [2]. 2. The method for producing a halopolycyclic aromatic compound as described in 1 above.

3.下記一般式[2]で表される化合物と下記一般式[3]で表される化合物を遷移金属触媒の存在下反応させて下記一般式[4]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。   3. A compound represented by the following general formula [2] and a compound represented by the following general formula [3] are reacted in the presence of a transition metal catalyst to produce a halopolycyclic aromatic compound represented by the following general formula [4]. A process for producing a halopolycyclic aromatic compound, characterized in that it is produced.

(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。X、Xはハロゲン原子を表す。Zは芳香族炭化水素環または芳香族複素環を形成するのに必要な非金属原子群を表す。)
4.下記一般式[2]で表されるハロ多環芳香族化合物。
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other binding to which may form a ring .X 1 is the .X 2, X 3 representing an oxygen atom or a sulfur atom is .Z represents a halogen atom to form an aromatic hydrocarbon ring or aromatic heterocyclic ring Represents a group of non-metallic atoms necessary for
4). A halopolycyclic aromatic compound represented by the following general formula [2].

(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。Xはハロゲン原子を表す。)
5.下記一般式[5]で表される前記4に記載のハロ多環芳香族化合物。
(式中、R 、R は水素原子またはメチル基を表す。R 、R はヒドロキシ基または アルコキシ基を表す。R とR はお互いに結合して環を形成してもよい。X は酸素原 子または硫黄原子を表す。X はハロゲン原子を表す。)
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other bound good .X 1 to form a ring with the .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)
5). 5. The halopolycyclic aromatic compound according to the above 4, represented by the following general formula [5].
(In the formula, R 1 and R 2 represent a hydrogen atom or a methyl group. R 3 and R 4 represent a hydroxy group or an alkoxy group. R 3 and R 4 may be bonded to each other to form a ring. .X 1 is .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)

有機合成化合物の中間体、特に有機エレクトロルミネッセンス材料の中間体として有用なハロ多環芳香族化合物は、本発明の製造方法により高収率で得られる。   A halopolycyclic aromatic compound useful as an intermediate of an organic synthetic compound, particularly as an intermediate of an organic electroluminescent material, can be obtained in a high yield by the production method of the present invention.

以下、本発明を更に詳細に述べる。   Hereinafter, the present invention will be described in more detail.

一般式[1]、一般式[2]、一般式[3]及び一般式[4]において、R1及びR2で表される置換基としては、例えば、アルキル、シクロアルキル、アルケニル、アリール、アシルアミノ、スルホンアミド、アルキルチオ、アリールチオ、ハロゲン原子、複素環、スルホニル、スルフィニル、ホスホニル、アシル、カルバモイル、スルファモイル、シアノ、アルコキシ、アリールオキシ、複素環オキシ、シロキシ、アシルオキシ、カルバモイルオキシ、アミノ、アルキルアミノ、イミド、ウレイド、スルファモイルアミノ、アルコキシカルボニルアミノ、アルコキシカルボニルアミノ、アリールオキシカルボニルアミノ、アルコキシカルボニル、アリールオキシカルボニル、カルボキシル等の各基が挙げられる。In general formula [1], general formula [2], general formula [3], and general formula [4], examples of the substituent represented by R 1 and R 2 include alkyl, cycloalkyl, alkenyl, aryl, Acylamino, sulfonamido, alkylthio, arylthio, halogen atom, heterocycle, sulfonyl, sulfinyl, phosphonyl, acyl, carbamoyl, sulfamoyl, cyano, alkoxy, aryloxy, heterocycleoxy, siloxy, acyloxy, carbamoyloxy, amino, alkylamino, Examples include imide, ureido, sulfamoylamino, alkoxycarbonylamino, alkoxycarbonylamino, aryloxycarbonylamino, alkoxycarbonyl, aryloxycarbonyl, carboxyl and the like.

1は酸素原子、硫黄原子またはイミノ基を表し、イミノ基としてはアルキルまたはアリールで置換されたイミノ基が好ましい。これらの内、好ましいものは酸素原子である。X2で表されるハロゲン原子として、好ましいものは臭素原子である。X 1 represents an oxygen atom, a sulfur atom or an imino group, and the imino group is preferably an imino group substituted with alkyl or aryl. Of these, preferred is an oxygen atom. The halogen atom represented by X 2 is preferably a bromine atom.

及びRヒドロキシ基またはアルコキシ基を表す。R及びRで表されるアルコキシ基として、例えば、メトキシ基、更には環を形成するところの−OC(CHC(CHO−、−OCHCH(CH)CHO−等が挙げられる。R及びRで表される基の内、好ましいものはヒドロキシ基、−OC(CHC(CHO−であり、より好ましくはヒドロキシ基である。R 3 and R 4 represent a hydroxy group or an alkoxy group. Examples of the alkoxy group represented by R 3 and R 4 include a methoxy group, and further —OC (CH 3 ) 2 C (CH 3 ) 2 O— and —OCH 2 CH (CH 3 ) forming a ring. CH 2 O- and the like. Among the groups represented by R 3 and R 4 , preferred are a hydroxy group, —OC (CH 3 ) 2 C (CH 3 ) 2 O—, and more preferred is a hydroxy group.

Zと共に形成される芳香族炭化水素環及び芳香族複素環としては、例えば、ベンゼン環、ビフェニル環、ナフタレン環、カルバゾール環、フラン環、チオフェン環、ピリジン環、ピリダジン環、ピリミジン環、ピラジン環、トリアジン環、ベンゾイミダゾール環、オキサジアゾール環、トリアゾール環、イミダゾール環、ピラゾール環、チアゾール環、インドール環、ベンゾイミダゾール環、ベンゾチアゾール環、ベンゾオキサゾール環、キノキサリン環、キナゾリン環、フタラジン環、カルボリン環、ジアザカルバゾール環(カルボリン環を構成する炭化水素環の炭素原子の一つが更に窒素原子で置換されている環を示す)等が挙げられる。これらの内、好ましいものはベンゼン環及びカルバゾール環である。   Examples of the aromatic hydrocarbon ring and aromatic heterocycle formed together with Z include, for example, a benzene ring, biphenyl ring, naphthalene ring, carbazole ring, furan ring, thiophene ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, Triazine ring, benzimidazole ring, oxadiazole ring, triazole ring, imidazole ring, pyrazole ring, thiazole ring, indole ring, benzimidazole ring, benzothiazole ring, benzoxazole ring, quinoxaline ring, quinazoline ring, phthalazine ring, carboline ring And a diazacarbazole ring (showing a ring in which one of the carbon atoms of the hydrocarbon ring constituting the carboline ring is further substituted with a nitrogen atom). Of these, preferred are a benzene ring and a carbazole ring.

上記の基はいずれも更に置換基によって置換されていてもよく、置換基としては、例えば、アルキル、シクロアルキル、アルケニル、アリール、アシルアミノ、スルホンアミド、アルキルチオ、アリールチオ、ハロゲン原子、複素環、スルホニル、スルフィニル、ホスホニル、アシル、カルバモイル、スルファモイル、シアノ、アルコキシ、アリールオキシ、複素環オキシ、シロキシ、アシルオキシ、カルバモイルオキシ、アミノ、アルキルアミノ、イミド、ウレイド、スルファモイルアミノ、アルコキシカルボニルアミノ、アルコキシカルボニルアミノ、アリールオキシカルボニルアミノ、アルコキシカルボニル、アリールオキシカルボニル、カルボキシル等の各基が挙げられる。   Any of the above groups may be further substituted with a substituent. Examples of the substituent include alkyl, cycloalkyl, alkenyl, aryl, acylamino, sulfonamido, alkylthio, arylthio, halogen atom, heterocycle, sulfonyl, Sulfinyl, phosphonyl, acyl, carbamoyl, sulfamoyl, cyano, alkoxy, aryloxy, heterocyclic oxy, siloxy, acyloxy, carbamoyloxy, amino, alkylamino, imide, ureido, sulfamoylamino, alkoxycarbonylamino, alkoxycarbonylamino, Examples include aryloxycarbonylamino, alkoxycarbonyl, aryloxycarbonyl, carboxyl and the like.

以下、本発明に一般式[1]、一般式[2]、一般式[3]及び一般式[4]で表される化合物の代表的具体例を示すが、本発明はこれらに限定されものではない。   Hereinafter, typical specific examples of the compounds represented by the general formula [1], the general formula [2], the general formula [3], and the general formula [4] are shown in the present invention, but the present invention is not limited thereto. is not.

一般式[2]で表される化合物は、一般式[1]とリチオ化剤を反応させた後、ボロン酸誘導体と反応することで得ることができる。   The compound represented by the general formula [2] can be obtained by reacting the general formula [1] with a lithiating agent and then reacting with a boronic acid derivative.

リチオ化剤としては、例えば、メチルリチウム、n−ブチルリチウム、sec−ブチルリチウム、t−ブチルリチウム及びn−ヘキシルリチウム等が挙げられる。これらの内で好ましいものはn−ブチルリチウムである。ボロン酸誘導体としては、例えば、トリメチルボレート、トリブチルボレート、2−イソプロボキシ−4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン等が挙げられる。これらの内で好ましいものはトリメチルボレートである。   Examples of the lithiating agent include methyl lithium, n-butyl lithium, sec-butyl lithium, t-butyl lithium, and n-hexyl lithium. Of these, n-butyllithium is preferred. Examples of the boronic acid derivative include trimethyl borate, tributyl borate, 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane and the like. Of these, trimethyl borate is preferred.

反応は通常−80〜0℃で行われるのが好ましく、−80〜−50℃で行われるのが特に好ましい。   The reaction is usually preferably performed at -80 to 0 ° C, particularly preferably at -80 to -50 ° C.

一般式[4]で表される化合物は、遷移金属触媒の存在下、一般式[2]で表される化合物と一般式[3]で表される化合物との反応で得ることができる。   The compound represented by the general formula [4] can be obtained by the reaction of the compound represented by the general formula [2] and the compound represented by the general formula [3] in the presence of a transition metal catalyst.

遷移金属触媒としては、例えば、パラジウム錯体(PdCl2、Pd(OAc)2、Pd(PPh34、PdCl2dppf、Pd(dba)2、Pd/C)、ニッケル錯体(NiBr2、NiBr2(PPh32、Ni(acac)2、Bis(1,5−cyclooctadiene)Ni(0))、亜鉛等が挙げられる。これらの内で好ましいものはパラジウム錯体である。Examples of the transition metal catalyst include palladium complexes (PdCl 2 , Pd (OAc) 2 , Pd (PPh 3 ) 4 , PdCl 2 dppf, Pd (dba) 2 , Pd / C), nickel complexes (NiBr 2 , NiBr 2). (PPh 3 ) 2 , Ni (acac) 2 , Bis (1,5-cyclotadiene) Ni (0)), zinc and the like. Among these, a palladium complex is preferable.

更に金属触媒と共に以下の化合物を添加してもよい。例えば、4級アンモニウム塩(TBAF(フッ化テトラブチルアンモニウム)、ヨウ化テトラエチルアンモニウム)、2,2′−ビピリジン、トリ(t−ブチル)ホスフィン、DPPE(Bis(diphenylphosphino)ethane)、DPPP(Bis(diphenylphosphino)propane)、DPPB(Bis(diphenylphosphino)butane)、DPPF(1,1′−Bis(diphenylphosphino)ferrocene)、PCy3(Tricyclohexylphosphine)等が挙げられる。Further, the following compounds may be added together with the metal catalyst. For example, quaternary ammonium salts (TBAF (tetrabutylammonium fluoride), tetraethylammonium iodide), 2,2′-bipyridine, tri (t-butyl) phosphine, DPPE (Bis (diphenylphosphino) ethane), DPPP (Bis ( diphenylphosphino) propane), DPPB (Bis (diphenylphosphino) butane), DPPF (1,1′-Bis (diphenylphosphino) ferrocene), PCy 3 (Tricyclohexylphosphine) and the like.

更に上記反応には塩基が用いられる。塩基としては、例えば、アルカリ金属塩(炭酸ナトリウム、炭酸カリウム、炭酸水素ナトリウム、炭酸セシウム、フッ化セシウム等)、アミン誘導体(トリエチルアミン等)等が挙げられる。   Furthermore, a base is used in the above reaction. Examples of the base include alkali metal salts (sodium carbonate, potassium carbonate, sodium hydrogen carbonate, cesium carbonate, cesium fluoride, etc.), amine derivatives (triethylamine, etc.) and the like.

反応は通常60〜130℃で行われるのが好ましく、70〜100℃で行われるのが特に好ましい。   The reaction is usually preferably carried out at 60 to 130 ° C, particularly preferably 70 to 100 ° C.

以下に実施例を挙げて本発明を具体的に説明するが、本発明の実施態様はこれに限定されるものではない。   Hereinafter, the present invention will be specifically described with reference to examples. However, the embodiment of the present invention is not limited thereto.

実施例1(比較実施例)
《化合物Dの合成》
Example 1 (Comparative Example)
<< Synthesis of Compound D >>

例示化合物1−1、6.30g、カルバゾール2.9g(×0.9mol)、炭酸カリウム4.0g(×1.5mol)、Cu粉3.68g(×3mol)、脱水DMAc75mlを混合し、窒素気流下、30時間攪拌した(内温145〜147℃)。不溶分を減圧濾過し、濾液をTHFで抽出した後、減圧蒸留で溶媒を除去した。カラムクロマトグラフィー(充填剤:シリカゲル、展開液:トルエン/n−ヘキサン)で精製し、化合物Bを0.48g(収率6.0%)得た。   Exemplified compound 1-1, 6.30 g, carbazole 2.9 g (× 0.9 mol), potassium carbonate 4.0 g (× 1.5 mol), Cu powder 3.68 g (× 3 mol), dehydrated DMAc 75 ml are mixed, and nitrogen is mixed. The mixture was stirred for 30 hours under an air stream (internal temperature: 145 to 147 ° C.). Insoluble matter was filtered under reduced pressure, and the filtrate was extracted with THF, and then the solvent was removed by distillation under reduced pressure. Purification by column chromatography (filler: silica gel, developing solution: toluene / n-hexane) gave 0.48 g (yield 6.0%) of Compound B.

次に窒素気流下、化合物B、0.48g、化合物C、0.43g、エチレングリコールジメチルエーテル50ml、15%炭酸カリウム水溶液2.5ml、Pd(Pph340.080gを投入し、5時間還流した。反応液を水洗後、減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、化合物D、0.13g(収率20.0%)を得た。Next, under a nitrogen stream, Compound B, 0.48 g, Compound C, 0.43 g, Ethylene glycol dimethyl ether 50 ml, 15% aqueous potassium carbonate solution 2.5 ml, Pd (Pph 3 ) 4 0.080 g were charged and refluxed for 5 hours. did. The reaction solution was washed with water and filtered under reduced pressure. The resulting crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain Compound D (0.13 g, yield 20.0%).

実施例2(本発明実施例)
《化合物Dの合成》
Example 2 (Example of the present invention)
<< Synthesis of Compound D >>

窒素気流下、例示化合物1−1、81.5gを脱水THF、1Lに投入し、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−72℃まで冷却した。n−BuLi(2.6M)97.1mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、B(OCH3360.1gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトン浴を解除した。Under a nitrogen stream, 81.5 g of Exemplified Compound 1-1 was added to 1 L of dehydrated THF, and stirred and dissolved at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −72 ° C. in a dry ice / acetone bath. 97.1 ml of n-BuLi (2.6M) was added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, and the mixture was stirred for 1 hour. Subsequently, 60.1 g of B (OCH 3 ) 3 was added dropwise at an internal temperature of −70 ° C. or less for 1 hour to release the dry ice / acetone bath.

2時間後(内温20℃)に10%HCl、l300ml(×3.3mol)を投入した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮でスラリー状とし、これにアセトニトリルを加え、析出した結晶を減圧濾過し、例示化合物2−1、50.9g(収率70%)を得た。   Two hours later (internal temperature 20 ° C.), 10% HCl, 300 ml (× 3.3 mol) was added. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure to form a slurry, acetonitrile was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain 50.9 g (yield 70%) of Exemplary Compound 2-1.

次に窒素気流下、例示化合物2−1、11.7g、例示化合物3−3、18.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−3、10g(収率57.4%)を得た。Next, Example Compound 2-1, 11.7 g, Example Compound 3-3, 18.5 g, 10.4 g of potassium carbonate, DMSO, 600 ml are mixed under a nitrogen stream, and further PdCl 2 dppf 1.60 g is added, and 90 The mixture was stirred at around 0 ° C for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain Exemplified Compounds 4-3 and 10 g (yield 57.4%).

次に窒素気流下、Pd(OAc)20.30g、P(But)31.0g、脱水キシレン10mlを40℃で10分攪拌した。例示化合物4−3、5.0g、例示化合物3−3、1.9g、NaOBu−t、1.2g、脱水キシレン100mlを投入し、4時間還流した。反応液を水洗後、減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、化合物D、3.60g(収率61.4%)を得た。Next, 0.30 g of Pd (OAc) 2 , 1.0 g of P (But) 3 and 10 ml of dehydrated xylene were stirred at 40 ° C. for 10 minutes under a nitrogen stream. Exemplified Compound 4-3, 5.0 g, Exemplified Compound 3-3, 1.9 g, NaOBu-t, 1.2 g, and 100 ml of dehydrated xylene were added and refluxed for 4 hours. The reaction solution was washed with water and filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 3.60 g (yield 61.4%) of Compound D.

有機エレクトロルミネッセンス材料(化合物D)の製造方法である実施例1、2から、本発明の製造方法である実施例2は、明らかに高収率であることが分かる。   From Examples 1 and 2 which are manufacturing methods of an organic electroluminescent material (compound D), it can be seen that Example 2 which is a manufacturing method of the present invention clearly has a high yield.

実施例3(本発明実施例)
《例示化合物4−8の合成》
Example 3 (Example of the present invention)
<< Synthesis of Exemplified Compound 4-8 >>

窒素気流下、例示化合物1−6、47.5g、脱水THF、1Lを混ぜ、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−73℃まで冷却した。n−BuLi(2.6M)、56.6mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、ボロン酸エステル、28gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトン浴を解除した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮した。これにエタノールを加え、析出した結晶を減圧濾過し、例示化合物2−6、21.1gを得た。(収率39%)
窒素気流下、例示化合物2−6、15.4g、例示化合物3−8、15.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf、1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−8、8.4g(収率47.4%)を得た。
Under a nitrogen stream, Example Compound 1-6, 47.5 g, dehydrated THF, and 1 L were mixed and dissolved by stirring at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −73 ° C. in a dry ice / acetone bath. n-BuLi (2.6 M) and 56.6 ml were added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, and the mixture was stirred for 1 hour. Subsequently, 28 g of boronic acid ester was added dropwise at an internal temperature of −70 ° C. or less for 1 hour to release the dry ice / acetone bath. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure. Ethanol was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain 21.1 g of exemplified compound 2-6. (Yield 39%)
Under nitrogen stream, Exemplified Compound 2-6, 15.4 g, Exemplified Compound 3-8, 15.5 g, Potassium Carbonate 10.4 g, DMSO, 600 ml were mixed, and PdCl 2 dppf, 1.60 g was added, and 90 The mixture was stirred at around 0 ° C for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 8.4 g (yield 47.4%) of Exemplary Compound 4-8.

実施例4(本発明実施例)
《例示化合物4−4の合成》
Example 4 (Example of the present invention)
<< Synthesis of Exemplified Compound 4-4 >>

窒素気流下、例示化合物1−3、85.5g、脱水THF、1Lを混ぜ、内温25〜30℃で攪拌溶解した。次に、ドライアイス/アセトン浴で内温−70℃まで冷却した。n−BuLi(2.6M)、97.1mlを内温−70℃以下、2.5時間で滴下し、1時間攪拌した。続いて、B(OCH33、60.1gを内温−70℃以下、1時間で滴下し、ドライアイス/アセトンを解除した。2時間後(内温20℃)に10%HCl、300ml(×3.3mol)を投入した。分液ロートに移し、食塩水で洗浄した。THF溶液を減圧濃縮でスラリー状とし、これにアセトニトリルを加え、析出した結晶を減圧濾過し、例示化合物2−3、39.9gを得た。(収率52%)
次に窒素気流下、例示化合物2−3、12.3g、例示化合物3−3、18.5g、炭酸カリウム10.4g、DMSO、600mlを混合し、更にPdCl2dppf、1.60gを添加し、90℃付近で2時間攪拌した。水100mlを加え、析出した結晶を減圧濾過した。得られた粗結晶をカラムクロマトグラフィー(シリカゲル、トルエン/へキサン)にて精製し、例示化合物4−4、8.3g(収率41%)を得た。
Under a nitrogen stream, Exemplified Compound 1-3, 85.5 g, dehydrated THF, and 1 L were mixed and dissolved by stirring at an internal temperature of 25 to 30 ° C. Next, it was cooled to an internal temperature of −70 ° C. with a dry ice / acetone bath. n-BuLi (2.6M), 97.1 ml, was added dropwise at an internal temperature of −70 ° C. or less for 2.5 hours, followed by stirring for 1 hour. Subsequently, 60.1 g of B (OCH 3 ) 3 was added dropwise over 1 hour at an internal temperature of −70 ° C. or less to release dry ice / acetone. Two hours later (internal temperature 20 ° C.), 10% HCl and 300 ml (× 3.3 mol) were added. It was transferred to a separatory funnel and washed with brine. The THF solution was concentrated under reduced pressure to form a slurry, acetonitrile was added thereto, and the precipitated crystals were filtered under reduced pressure to obtain Exemplified Compound 2-3 (39.9 g). (Yield 52%)
Next, under a nitrogen stream, Example Compound 2-3, 12.3 g, Example Compound 3-3, 18.5 g, 10.4 g of potassium carbonate, DMSO, 600 ml are mixed, and PdCl 2 dppf, 1.60 g is added. The mixture was stirred at around 90 ° C. for 2 hours. 100 ml of water was added, and the precipitated crystals were filtered under reduced pressure. The obtained crude crystals were purified by column chromatography (silica gel, toluene / hexane) to obtain 8.3 g (yield 41%) of Exemplary Compound 4-4.

実施例5(本発明実施例)
《例示化合物4−1の合成》
Example 5 (Example of the present invention)
<< Synthesis of Exemplary Compound 4-1 >>

窒素気流下、例示化合物3−1、32.9g、例示化合物2−1、64.0g、エチレングリコールジメチルエーテル1.5L、炭酸カリウム58.0g、水350ml、Pd(Pph347.0gを投入し、還流12時間行った。析出した結晶を濾過、乾燥した。THF4.8Lを投入し加熱溶解し、不溶分を除去後、300mlまで濃縮し、アセトニトリル300mlを滴下し、1時間攪拌した。析出した結晶を濾過し、例示化合物4−1、40.3g(収率71.0%)を得た。Under a nitrogen stream, Example Compound 3-1, 32.9 g, Example Compound 2-1, 64.0 g, Ethylene glycol dimethyl ether 1.5 L, Potassium carbonate 58.0 g, Water 350 ml, Pd (Pph 3 ) 4 7.0 g Charged and refluxed for 12 hours. The precipitated crystals were filtered and dried. 4.8 L of THF was added and dissolved by heating. After removing insolubles, the solution was concentrated to 300 ml, 300 ml of acetonitrile was added dropwise and stirred for 1 hour. The precipitated crystals were filtered to obtain 40.3 g (yield 71.0%) of Exemplary Compound 4-1.

実施例中の各化合物の同定はMASS及びNMRスペクトルで行い、それぞれ目的化合物であることを確認した。その他の例示化合物も上記の方法に準じて合成することができる。   Each compound in the examples was identified by MASS and NMR spectra to confirm that it was the target compound. Other exemplary compounds can also be synthesized according to the above method.

Claims (5)

下記一般式[1]で表される化合物を用い下記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。
(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。Xはハロゲン原子を表す。)
The manufacturing method of the halo polycyclic aromatic compound characterized by manufacturing the halo polycyclic aromatic compound represented by the following general formula [2] using the compound represented by the following general formula [1].
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other bound good .X 1 to form a ring with the .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)
前記一般式[1]で表される化合物を用い、リチオ化剤を反応させた後、ボロン酸誘導体と反応させて前記一般式[2]で表されるハロ多環芳香族化合物を製造することを特徴とする請求項1に記載のハロ多環芳香族化合物の製造方法。The compound represented by the general formula [1] is reacted with a lithiating agent and then reacted with a boronic acid derivative to produce a halopolycyclic aromatic compound represented by the general formula [2]. The method for producing a halopolycyclic aromatic compound according to claim 1 . 下記一般式[2]で表される化合物と下記一般式[3]で表される化合物を遷移金属触媒の存在下反応させて下記一般式[4]で表されるハロ多環芳香族化合物を製造することを特徴とするハロ多環芳香族化合物の製造方法。
(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。X、Xはハロゲン原子を表す。Zは芳香族炭化水素環または芳香族複素環を形成するのに必要な非金属原子群を表す。)
A compound represented by the following general formula [2] and a compound represented by the following general formula [3] are reacted in the presence of a transition metal catalyst to produce a halopolycyclic aromatic compound represented by the following general formula [4]. A process for producing a halopolycyclic aromatic compound, characterized in that it is produced.
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other binding to which may form a ring .X 1 is the .X 2, X 3 representing an oxygen atom or a sulfur atom is .Z represents a halogen atom to form an aromatic hydrocarbon ring or aromatic heterocyclic ring Represents a group of non-metallic atoms necessary for
下記一般式[2]で表されるハロ多環芳香族化合物。
(式中、R、Rは置換基を表し、n1、n2は0〜3の整数を表す。R、R ドロキシ基またはアルコキシ基を表す。RとRはお互いに結合して環を形成してもよい。Xは酸素原子または硫黄原子を表す。Xはハロゲン原子を表す。)
A halopolycyclic aromatic compound represented by the following general formula [2].
(Wherein, R 1, R 2 represents a substituent, n1, n2 are .R 3 represents an integer of 0 to 3, R 4 is .R 3 and R 4 representing a human Dorokishi group or an alkoxy group each other bound good .X 1 to form a ring with the .X 2 representing an oxygen atom or a sulfur atom represents a halogen atom.)
下記一般式[5]で表される請求項4に記載のハロ多環芳香族化合物。The halopolycyclic aromatic compound according to claim 4 represented by the following general formula [5].
(式中、R(Wherein R 1 、R, R 2 は水素原子またはメチル基を表す。RRepresents a hydrogen atom or a methyl group. R 3 、R, R 4 はヒドロキシ基またはIs a hydroxy group or アルコキシ基を表す。RRepresents an alkoxy group. R 3 とRAnd R 4 はお互いに結合して環を形成してもよい。XMay be bonded to each other to form a ring. X 1 は酸素原Is oxygen field 子または硫黄原子を表す。XRepresents a child or sulfur atom. X 2 はハロゲン原子を表す。)Represents a halogen atom. )
JP2009551442A 2008-01-31 2009-01-06 Halopolycyclic aromatic compound and method for producing the same Expired - Fee Related JP5381718B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009551442A JP5381718B2 (en) 2008-01-31 2009-01-06 Halopolycyclic aromatic compound and method for producing the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2008020540 2008-01-31
JP2008020540 2008-01-31
JP2009551442A JP5381718B2 (en) 2008-01-31 2009-01-06 Halopolycyclic aromatic compound and method for producing the same
PCT/JP2009/050025 WO2009096202A1 (en) 2008-01-31 2009-01-06 Halogenated polycyclic aromatic compound and method for producing the same

Publications (2)

Publication Number Publication Date
JPWO2009096202A1 JPWO2009096202A1 (en) 2011-05-26
JP5381718B2 true JP5381718B2 (en) 2014-01-08

Family

ID=40912555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551442A Expired - Fee Related JP5381718B2 (en) 2008-01-31 2009-01-06 Halopolycyclic aromatic compound and method for producing the same

Country Status (2)

Country Link
JP (1) JP5381718B2 (en)
WO (1) WO2009096202A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102325753B (en) 2008-12-19 2014-09-10 百时美施贵宝公司 Carbazole carboxamide compounds useful as kinase inhibitors
JP5623996B2 (en) * 2010-09-21 2014-11-12 株式会社半導体エネルギー研究所 Carbazole derivatives
JP5856266B2 (en) * 2010-09-21 2016-02-09 株式会社半導体エネルギー研究所 Organic semiconductor device
JP5831068B2 (en) * 2011-09-13 2015-12-09 コニカミノルタ株式会社 Process for producing fused heterocyclic compound
JP2014110276A (en) 2012-11-30 2014-06-12 Samsung Display Co Ltd Hole transport material for organic electroluminescent element and organic electroluminescent element using the same
US9172047B2 (en) 2012-11-30 2015-10-27 Samsung Display Co., Ltd. Hole transport material for organic electroluminescence device and organic electroluminescence device using the same
TW201718581A (en) 2015-10-19 2017-06-01 英塞特公司 Heterocyclic compounds as immunomodulators
EP4141002A1 (en) 2015-11-19 2023-03-01 Incyte Corporation Heterocyclic compounds as immunomodulators
US20170174679A1 (en) 2015-12-22 2017-06-22 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2017130977A1 (en) 2016-01-29 2017-08-03 住友化学株式会社 Composition, phosphorescent compound, and light-emitting element
WO2017192961A1 (en) 2016-05-06 2017-11-09 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2017205464A1 (en) 2016-05-26 2017-11-30 Incyte Corporation Heterocyclic compounds as immunomodulators
MD3472167T2 (en) 2016-06-20 2023-02-28 Incyte Corp Heterocyclic compounds as immunomodulators
MA45669A (en) 2016-07-14 2019-05-22 Incyte Corp HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS
EP3504198B1 (en) 2016-08-29 2023-01-25 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018119221A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Pyridine derivatives as immunomodulators
WO2018119266A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Benzooxazole derivatives as immunomodulators
WO2018119236A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
US11532790B2 (en) 2017-04-27 2022-12-20 Sumitomo Chemical Company, Limited Composition and light emitting device using the same
CN110546781B (en) 2017-04-27 2022-05-10 住友化学株式会社 Light emitting element
LT3774791T (en) 2018-03-30 2023-04-11 Incyte Corporation Heterocyclic compounds as immunomodulators
EP3790877B1 (en) 2018-05-11 2023-03-01 Incyte Corporation Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators
CA3150434A1 (en) 2019-08-09 2021-02-18 Incyte Corporation Salts of a pd-1/pd-l1 inhibitor
AU2020357514A1 (en) 2019-09-30 2022-04-07 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
JP2023500395A (en) 2019-11-11 2023-01-05 インサイト・コーポレイション Salts and Crystal Forms of PD-1/PD-L1 Inhibitors
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
CN116670114A (en) 2020-11-06 2023-08-29 因赛特公司 Methods for preparing PD-1/PD-L1 inhibitors, and salts and crystalline forms thereof
TW202233615A (en) 2020-11-06 2022-09-01 美商英塞特公司 Crystalline form of a pd-1/pd-l1 inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529471A (en) * 1998-11-06 2002-09-10 コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション Hydroboronation method
JP2007211237A (en) * 2005-12-28 2007-08-23 Sumitomo Chemical Co Ltd Block copolymer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529471A (en) * 1998-11-06 2002-09-10 コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション Hydroboronation method
JP2007211237A (en) * 2005-12-28 2007-08-23 Sumitomo Chemical Co Ltd Block copolymer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013025124; Xing Xiao, et al.: Journal of Polymer Science, Part A: Polymer Chemistry 45(12), 2007, 2410-2424 *

Also Published As

Publication number Publication date
JPWO2009096202A1 (en) 2011-05-26
WO2009096202A1 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
JP5381718B2 (en) Halopolycyclic aromatic compound and method for producing the same
ES2585221T3 (en) A process for the preparation of 6- (7 - ((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -n-methyl-1-naphthamide and synthetic intermediates thereof
CN104447599B (en) A kind of tetrazole heterogeneous ring compound and preparation method thereof
Shu et al. Facile and controllable synthesis of multiply substituted benzenes via a formal [3+ 3] cycloaddition approach
JP2010235575A (en) Method of producing nitrogen-containing condensed heterocyclic compound
CN109438317B (en) Preparation method of nitrogen-alkyl (deuterated alkyl) aromatic heterocycle and alkyl (deuterated alkyl) aryl ether compound
CN110117237A (en) A kind of preparation method of aromatic nitriles or alkenyl nitrile compounds
KR20100101315A (en) Process for preparing phenanthridine derivatives using trifluoroacetic acid
JP2012188414A (en) Improvement of method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, intermediate of etoricoxib
WO2021117767A1 (en) Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative
JP2008056615A (en) Vinylethynylaryl carboxylic acid, method for producing the same, and method for producing heat cross-linking compound by using the same
JP2009046408A (en) Dihalo polycyclic aromatic compound, pyrrolyl polycyclic aromatic compound and method for producing the same
JP7179614B2 (en) Method for producing nitrogen-containing heterocyclic compound
JP5741091B2 (en) Method for producing nitrogen-containing fused heterocyclic compound
JP5209426B2 (en) Method for producing 1,2,4-oxadiazole derivative
CN107814757B (en) Method for synthesizing polysubstituted pyrrole derivative
JP2008069122A (en) Manufacturing method of nitrogen-containing polycyclic heterocyclic compound
KR101845935B1 (en) preparation method of pyridoisoindole derivatives
JP5505450B2 (en) Method for producing nitrogen-containing polycyclic heterocyclic compound
CN106083649B (en) A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4
KR20160074488A (en) Monoarylation of aromatic amines
JP6532737B2 (en) Process for producing heteroacene compound
JP2013053120A (en) New compound
JP5396997B2 (en) Method for producing nitrogen-containing fused heterocyclic compound
JP5900675B2 (en) Method for producing pyrrolyl polycyclic aromatic compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110614

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20110818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130725

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130916

R150 Certificate of patent or registration of utility model

Ref document number: 5381718

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees